Other
Ruijin Hospital North Shanghai Jiao Tong University School of Medicine
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed trials have results
Key Signals
2 recruiting
Enrollment Performance
Analytics
Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT07183878Not ApplicableRecruiting
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
Role: collaborator
NCT06549673Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
Role: collaborator
NCT04525729Phase 4Completed
Rituximab and RASi in Patients with IgAN
Role: collaborator
NCT05824390Phase 4Unknown
A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy
Role: collaborator
All 4 trials loaded